Cancer Pain

• FDA label_change · 2023-12-15
  FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)

  The FDA approved Rhodes Pharmaceuticals' supplemental application for MS CONTIN (morphine sulfate), resulting in updated labeling for the pr…

• FDA label_change · 2019-10-07
  FDA Approved: MORPHINE SULFATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA documents a supplemental application for Morphine Sulfate by Hikma Pharmaceuticals USA Inc., likely related to labeling changes for the …